| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. | Lancet Oncol | 2008 | 2.54 |
| 2 | First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer. | Oncol Rep | 2005 | 0.86 |
| 3 | Signal transduction pathways as novel therapy targets in lung cancer. | Lung Cancer | 2004 | 0.81 |
| 4 | Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer. | Eur J Cardiothorac Surg | 2004 | 0.79 |
| 5 | Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. | Lung Cancer | 2004 | 0.77 |
| 6 | Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. | Lung Cancer | 2004 | 0.75 |